How to Buy Integra Lifesciences Holdings Stock
Integra Lifesciences Holdings Corp
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments.
Integra Lifesciences Holdings stock last closed at $17.55, down 0.62% from the previous day, and has increased 24.91% in one year. It has overperformed other stocks in the Medical Devices industry by 1.24 percentage points. Integra Lifesciences Holdings stock is currently +101.72% from its 52-week low of $8.70, and -14.35% from its 52-week high of $20.49.
As of Aug 18, 2026, there are 77.77M shares of IART outstanding. The market cap of IART is $1.36B. In the past 24 hours, 535,000 IART shares were traded.
How to Buy Integra Lifesciences Holdings Stock
Not sure how to invest in Integra Lifesciences Holdings stock? Here's how.
- Figure out where to buy Integra Lifesciences Holdings stock: You need to pick an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Integra Lifesciences Holdings stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your info.
- Research Integra Lifesciences Holdings stock: The Integra Lifesciences Holdings ticker symbol is IART. Is Integra Lifesciences Holdings stock a good investment? Should you buy shares of IART? How do IART's underlying business fundamentals look? Do top analysts think Integra Lifesciences Holdings is a good buy? Why has IART's stock price moved recently? (Hint: Our stock research tools can help you figure out if IART is a good stock to buy).
- Execute your IART buy order: Decide if you will purchase IART shares at the current market price or use a limit order to buy IART shares at a particular price.
- Monitor your IART position: Create a watchlist to watch your position in Integra Lifesciences Holdings stock.
Step 1: Figure out where to buy Integra Lifesciences Holdings stock
You need a brokerage account to access the NASDAQ market and buy IART shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal details so you are able to invest in IART today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create your new trading account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on one of the most highly reviewed stock trading apps, you need to deposit funds:
Check out the video below if you need help transferring funds into your new investment account.
Step 4: Research Integra Lifesciences Holdings stock
Once you have chosen the best place to buy Integra Lifesciences Holdings stock, it's important to analyze their stock prior to buying, so you truly wrap your head around the risk and opportunity.
Overview of key IART info
IART Overview
WallStreetZen was created to help average investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on IART's stock page.
Is IART stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge IART's intrinsic value.
Using relative valuations metrics:
- IART may be undervalued based on its P/B ratio of 1.31x, relative to Medical Devices industry P/B ratio of 3.35x
You can access more valuation analysis on IART's stock here.
IART Financial Health Overview
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the IART balance sheet.
- IART profit margin has gone up from -30.9% to -0.4% in the past year.
Failed Financial Due Diligence Checks:
- IART's operating cash flow of $85.33M allows it to safely service it's debt of $2.05B.
- IART earnings of $91.68M is not sufficient to cover its interest payments.
- Total IART debt is higher than 5 years ago, relative to shareholder equity.
- There are more long-term liabilities than short-term assets on the IART balance sheet.
- IART has a relatively high debt to equity ratio of 2.42.
Is IART stock a Buy, Hold, or Sell, according to analysts?
Out of 6 sell side analysts who give ratings on IART, the consensus analyst rating on IART is a Hold
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest IART Analyst Forecasts
David Toung, a top 20% analyst from Argus Research downgrades IART to a hold rating, on Apr 15, 2026.
You can dig deeper into what analysts are forecasting on the Integra Lifesciences Holdings stock forecast page.
IART Technicals
IART Earnings
Last year, IART revenue was $1.65B. In the past 5 year, IART's revenue has grown by 1.77% per year. This was slower than the Medical Devices industry average of 8.78%.
Learn more about IART's earnings and revenue performance here.
Latest Insiders Trades at IART
Over the past 12 months, insiders at IART have sold more shares than they have bought.
Lea Daniels Knight, EVP Chief Financial Officer of IART, was the latest IART insider to sell. They sold $94,329.30 worth of IART shares on Jul 3, 2026.
Get more info about who owns IART stock here.
Does IART stock generate passive income?
No, Integra Lifesciences Holdings doesn't provide an income stream by paying out dividends.
What do other traders have to say about IART?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your IART buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally sufficient. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, place a limit order.
Click the Open button and eToro will execute the order.
If you require more help buying stocks on eToro, watch the helpful video below:
Step 6: Monitor your IART position
Now that you own some shares in IART, you'll want to keep up with your shares.
Start a watchlist to get notified of important updates regarding your IART stock.
IART Feed
How to Buy Stock in Integra Lifesciences Holdings
To reiterate, here are the 6 steps to buy Integra Lifesciences Holdings stock:
- Figure out where to buy Integra Lifesciences Holdings stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Research Integra Lifesciences Holdings stock
- Execute your IART buy order
- Monitor your IART position
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Integra Lifesciences Holdings, create a watchlist today.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.